Konstantinos Evangelou Selected Research

Konstantinos Evangelou Research Topics

Disease

12	Neoplasms (Cancer) 10/2021 - 02/2008
3	Infections 01/2022 - 01/2012
2	COVID-19 01/2022 - 10/2021
2	Carcinogenesis 09/2017 - 12/2011
2	Neoplasm Metastasis (Metastasis) 12/2011 - 10/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2008 - 11/2002
1	Chromosome Inversion (Chromosomal Inversion) 12/2021
1	Chromosomal Instability (Chromosome Stability) 10/2021
1	Breast Neoplasms (Breast Cancer) 05/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Multiple Sclerosis 09/2018
1	Parkinson Disease (Parkinson's Disease) 09/2018
1	Alzheimer Disease (Alzheimer's Disease) 09/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2017
1	Polyploidy 11/2016
1	Inflammation (Inflammations) 01/2014
1	Crohn Disease (Crohn's Disease) 01/2014
1	Systemic Scleroderma (Systemic Sclerosis) 02/2013
1	Autoimmune Diseases (Autoimmune Disease) 02/2013
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2013
1	Myxoma (Myxomas) 01/2012
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2010
1	Appendicitis 06/2010
1	Humoral Hypercalcemia Of Malignancy 10/2009
1	Hypercalcemia (Milk Alkali Syndrome) 10/2009
1	Carcinoma (Carcinomatosis) 07/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2002

Drug/Important Bio-Agent (IBA)

3	EnzymesIBA 01/2022 - 10/2021
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2012
2	Biological ProductsIBA 05/2021 - 02/2017
1	CytokinesIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	CytosineIBA 10/2021
1	FenbendazoleIBA 06/2021
1	titanium dioxide (Titania)FDA Link 05/2021
1	SilverIBA 05/2021
1	Polymethyl Methacrylate (Sol)IBA 05/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	InflammasomesIBA 01/2020
1	SenotherapeuticsIBA 01/2019
1	Coloring Agents (Dyes)IBA 09/2018
1	LipofuscinIBA 09/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2017
1	Beclin-1IBA 09/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016
1	Proteoglycans (Proteoglycan)IBA 01/2016
1	Syndecan-1 (Syndecan 1)IBA 01/2016
1	E2F Transcription FactorsIBA 08/2014
1	Infliximab (Remicade)FDA Link 01/2014
1	Phosphotransferases (Kinase)IBA 02/2013
1	Tyrosine (L-Tyrosine)FDA Link 02/2013
1	Pharmaceutical PreparationsIBA 02/2013
1	Imatinib Mesylate (Gleevec)FDA Link 02/2013
1	Formaldehyde (Formol)FDA Link 01/2012
1	ParaffinIBA 01/2012
1	Cadherins (E-Cadherin)IBA 12/2011
1	CalciumIBA 10/2009
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2009
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2009
1	Parathyroid Hormone (Parathormone)IBA 10/2009
1	ProteomeIBA 07/2009
1	3' Untranslated Regions (3' UTR)IBA 02/2008
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 02/2008
1	E2F1 Transcription FactorIBA 07/2004
1	beta CateninIBA 11/2002
1	Proteins (Proteins, Gene)FDA Link 11/2002

Therapy/Procedure

3	Therapeutics 01/2019 - 12/2008
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Appendectomy 06/2010
1	Colectomy 06/2010
1	Investigational Therapies (Experimental Therapy) 07/2009